References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492
- Wong YNS, Ferraldeschi R, Attard G, de Bono J. Evolution of androgen receptor targeted therapy for advanced prostate cancer. Nat Rev Clin Oncol. 2014;11(6):365–376. doi:https://doi.org/10.1038/nrclinonc.2014.72
- Yu J, Yu J, Mani R-S, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M, et al. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell. 2010;17(5):443–454. doi:https://doi.org/10.1016/j.ccr.2010.03.018
- Semenas J, Dizeyi N, Jl P. Enzalutamide as a second-generation antiandrogen for treatment of advanced prostate cancer. Drug Des Dev Ther. 2013;7:875–881.
- Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. doi:https://doi.org/10.1126/science.1160809
- Liu X, Strable MG, Ntambi JM. Stearoyl CoA desaturase 1: role in cellular inflammation and stress. Adv Nutr. 2011;2(1):15–22. doi:https://doi.org/10.3945/an.110.000125
- Piao C, Cui X, Zhan B, Li J, Li Z, Li Z, Liu X, Bi J, Zhang Z, Kong C, et al. Inhibition of stearoyl CoA desaturase-1 activity suppresses tumour progression and improves prognosis in human bladder cancer. J Cell Mol Med. 2019;23(3):2064–2076.: doi:https://doi.org/10.1111/jcmm.14114
- Tracz-Gaszewska Z, Dobrzyn P. Stearoyl-CoA desaturase 1 as a therapeutic target for the treatment of cancer. Cancers. 2019;11(7):948. doi:https://doi.org/10.3390/cancers11070948
- Galbraith L, Leung HY, Ahmad I. Lipid pathway deregulation in advanced prostate cancer. Pharmacol Res. 2018;131:177–184. doi:https://doi.org/10.1016/j.phrs.2018.02.022
- Tutino V, Gigante I, Scavo MP, Refolo MG, De Nunzio V, Milella RA, Caruso MG, Notarnicola M. Stearoyl-CoA desaturase-1 enzyme inhibition by grape skin extracts affects membrane fluidity in human colon cancer cell lines. Nutrients. 2020;12(3):693. doi:https://doi.org/10.3390/nu12030693
- Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care. 2006;9(4):358–365. doi:https://doi.org/10.1097/01.mco.0000232894.28674.30
- Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition. 2000;16(3):202–208. doi:https://doi.org/10.1016/S0899-9007(99)00266-X
- Gomez EF, Bauman DE, Ntambi JM, Fox BG. Effects of sterculic acid on stearoyl-CoA desaturase in differentiating 3T3L1 adipocytes. Biochem Biophys Res Commun. 2003;300(2):316–326. doi:https://doi.org/10.1016/S0006-291X(02)02842-5
- Igal RA. Roles of stearoylCoA desaturase-1 in the regulation of cancer cell growth, survival and tumorigenesis. Cancers (Basel)). 2011;3(2):2462–2477. doi:https://doi.org/10.3390/cancers3022462
- Alsharari ZD, Risérus U, Leander K, Sjögren P, Carlsson AC, Vikström M, Laguzzi F, Gigante B, Cederholm T, De Faire U, et al. Serum fatty acids, desaturase activities and abdominal obesity - a population-based study of 60-year old men and women. PLoS One. 2017;12(1):e0170684: doi:https://doi.org/10.1371/journal.pone.0170684
- Warensjo E, Ohrvall M, Vessby B. Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr Metab Cardiovasc Dis. 2006;16(2):128–136. doi:https://doi.org/10.1016/j.numecd.2005.06.001
- Hodson L, Fielding BA. Stearoyl-CoA desaturase: rogue or innocent bystander?Prog Lipid Res. 2013;52(1):15–42. doi:https://doi.org/10.1016/j.plipres.2012.08.002
- Manni A, Richie JP, Schetter SE, Calcagnotto A, Trushin N, Aliaga C, El-Bayoumy K. Stearoyl-CoA desaturase-1, a novel target of omega-3 fatty acids for reducing breast cancer risk in obese postmenopausal women. Eur J Clin Nutr. 2017;71(6):762–765. doi:https://doi.org/10.1038/ejcn.2016.273
- Takahashi H, Nakayama R, Hayashi S, Nemoto T, Murase Y, Nomura K, Takahashi T, Kubo K, Marui S, Yasuhara K, et al. Macrophage migration inhibitory factor and stearoyl-CoA desaturase 1: potential prognostic markers for soft tissue sarcomas based on bioinformatics analyses. PLoS One. 2013;8(10):e78250: doi:https://doi.org/10.1371/journal.pone.0078250
- Hess D, Chisholm JW, Igal RA. Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLoS One. 2010;5(6):e11394. doi:https://doi.org/10.1371/journal.pone.0011394
- Uto Y. Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors. Chem Phys Lipids. 2016;197:3–12. doi:https://doi.org/10.1016/j.chemphyslip.2015.08.018
- Zhang Z, Dales NA, Winther MD. Opportunities and challenges in developing stearoyl-coenzyme A desaturase-1 inhibitors as novel therapeutics for human disease. J Med Chem. 2014;57(12):5039–5056. doi:https://doi.org/10.1021/jm401516c
- Fritz V, Benfodda Z, Rodier G, Henriquet C, Iborra F, Avancès C, Allory Y, de la Taille A, Culine S, Blancou H, et al. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol Cancer Ther. 2010;9(6):1740–1754. doi:https://doi.org/10.1158/1535-7163.MCT-09-1064
- Peck B, Schug ZT, Zhang Q, Dankworth B, Jones DT, Smethurst E, Patel R, Mason S, Jiang M, Saunders R, et al. Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments. Cancer Metab. 2016;4:6: doi:https://doi.org/10.1186/s40170-016-0146-8
- Guerrere M, Mondon JM, Pujaniaye A. Physicochemical composition of some seeds from plants of the Isle of Reunion. Ann Falsif Expert Chim Toxicol. 1985;78:281–286.
- Herrera-Meza MS, Mendoza-López MR, García-Barradas O, Sanchez-Otero MG, Silva-Hernández ER, Angulo JO, Oliart-Ros RM. Dietary anhydrous milk fat naturally enriched with conjugated linoleic acid and vaccenic acid modify cardiovascular risk biomarkers in spontaneously hypertensive rats. Int J Food Sci Nutr. 2013;64(5):575–586. doi:https://doi.org/10.3109/09637486.2013.763908
- Ramírez-Higuera A, Peña-Montes C, Herrera-Meza S, Mendoza-López R, Valerio-Alfaro G, Oliart-Ros RM. Preventive action of sterculic oil on metabolic syndrome development on a fructose-induced rat model. J Med Food. 2020;23(3):305–311. doi:https://doi.org/10.1089/jmf.2019.0177
- Ortinau LC, Nickelson KJ, Stromsdorfer KL, Naik CY, Pickering RT, Haynes RA, Fritsche KL, Perfield JW. Sterculic oil, a natural inhibitor of SCD1, improves the metabolic state of obese OLETF rats. Obesity (Silver Spring)). 2013;21(2):344–352. doi:https://doi.org/10.1002/oby.20040
- Ortinau LC, Pickering RT, Nickelson KJ, Stromsdorfer KL, Naik CY, Haynes RA, Bauman DE, Rector RS, Fritsche KL, Perfield JW, et al. Sterculic oil, a natural SCD1 inhibitor, improves glucose tolerance in obese ob/ob mice. ISRN Endocrinol. 2012;2012:947323. doi:https://doi.org/10.5402/2012/947323
- Kadegowda AK, Burns TA, Pratt SL, Duckett SK. Inhibition of stearoyl-CoA desaturase 1 reduces lipogenesis in primary bovine adipocytes. Lipids. 2013;48(10):967–976. doi:https://doi.org/10.1007/s11745-013-3823-1
- Bichi E, Toral PG, Hervás G, Frutos P, Gómez-Cortés P, Juárez M, de la Fuente MA. Inhibition of Δ9-desaturase activity with sterculic acid: effect on the endogenous synthesis of cis-9 18:1 and cis-9, trans-11 18:2 in dairy sheep. J Dairy Sci. 2012;95(9):5242–5252. doi:https://doi.org/10.3168/jds.2012-5349
- Peláez R, Pariente A, Pérez-Sala A, Larráyoz IM. Sterculic acid: the mechanisms of action beyond stearoyl-CoA desaturase inhibition and therapeutic opportunities in human diseases. Cells. 2020;9(1):140. doi:https://doi.org/10.3390/cells9010140
- Herrera-Meza S, Martínez AJ, Sánchez-Otero MG, Mendoza-López MR, García-Barradas O, Ortiz-Viveros GR, Oliart-Ros RM. Fatty acid composition and some physicochemical characteristics of Sterculia apetala seeds oil. Grasas Aceites. 2014;65(3):e039. doi:https://doi.org/10.3989/gya.0223141
- Benitez BG, Pulido-Salas MT, Equihua M. Árboles multiusos nativos de Veracruz para reforestación, restauración y plantaciones. Xalapa: Instituto de Ecología; 2004. p. 230–233.
- Nitao Z, Pushkar B, Queiroga V, Oliveira J. Sterculia striata seed kernel oil: characterization and thermal stability. Grasas Aceites. 2008;59:160–165.
- Lin JT, Li HY, Chang NS, Lin CH, Chen YC, Lu PJ. WWOX suppresses prostate cancer cell progression through cyclin D1-mediated cell cycle arrest in the G1 phase. Cell Cycle. 2015;14(3):408–416. doi:https://doi.org/10.4161/15384101.2014.977103
- Kim Y-H, Shin K-J, Lee TG, Kim E, Lee M-S, Ryu SH, Suh P-G. G2 arrest and apoptosis by 2-amino-N-quinoline-8-yl-benzenesulfonamide (QBS), a novel cytotoxic compound. Biochem Pharmacol. 2005;69(9):1333–1341. doi:https://doi.org/10.1016/j.bcp.2004.12.019
- Rao X, Huang X, Zhou Z, Lin X. An improvement of the 2" DDCT method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath. 2013;3:71–85.
- Pelícano-Esqueta M, Solanas M, Moral R, Costa I. Tumour cell membrane microdomains can be modified by dietary lipids on experimental breast cancer. Ann Nutr Metab. 2013;62:26–27.
- Kim SJ, Choi H, Park SS, Chang C, Kim E. Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation. Mol Cells. 2011;31(4):371–377. doi:https://doi.org/10.1007/s10059-011-0043-5
- Ostrander DB, Sparagna GC, Amoscato AA, McMillin JB, Dowhan W. Decreased cardiolipin synthesis corresponds with cytochrome C release in palmitate-induced cardiomyocyte apoptosis. J Biol Chem. 2001;276(41):38061–38067. doi:https://doi.org/10.1074/jbc.M107067200
- AbuAli G, Chaisaklert W, Stelloo E, Pazarentzos E, Hwang M-S, Qize D, Harding SV, Al-Rubaish A, Alzahrani AJ, Al-Ali A, et al. The anticancer gene ORCTL3 targets stearoyl-CoA desaturase-1 for tumour-specific apoptosis. Oncogene. 2015;34(13):1718–17128. doi:https://doi.org/10.1038/onc.2014.93
- Iwasawa R, Mahul-Mellier AL, Datler C, Pazarentzos E, Grimm S. Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction. Embo J. 2011;30(3):556–568. doi:https://doi.org/10.1038/emboj.2010.346
- Scaglia N, Igal RA. Inhibition of stearoyl‐CoA desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis. Int J Oncol. 2008;33(4):839–850.
- Mauvoisin D, Charfi C, Lounis AM, Rassart E, Mounier C. Decreasing stearoyl-CoA desaturase-1 expression inhibits β-catenin signaling in breast cancer cells. Cancer Sci. 2013;104(1):36–42. doi:https://doi.org/10.1111/cas.12032
- von Roemeling CA, Marlow LA, Pinkerton AB, Crist A, Miller J, Tun HW, Smallridge RC, Copland JA. Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target. J Clin Endocrinol Metab. 2015;100(5):E697–E709. doi:https://doi.org/10.1210/jc.2014-2764
- von Roemeling CA, Marlow LA, Wei JJ, Cooper SJ, Caulfield TR, Wu K, Tan WW, Tun HW, Copland JA. Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Clin Cancer Res. 2013;19(9):2368–2380. doi:https://doi.org/10.1158/1078-0432.CCR-12-3249
- Chen L, Ren J, Yang L, Li Y, Fu J, Li Y, Tian Y, Qiu F, Liu Z, Qiu Y, et al. Stearoyl-CoA desaturase-1 mediated cell apoptosis in colorectal cancer by promoting ceramide synthesis. Sci Rep. 2016;6:19665: doi:https://doi.org/10.1038/srep19665
- Li W, Bai H, Liu S, Cao D, Wu H, Shen K, Tai Y, Yang J. Targeting stearoyl-CoA desaturase 1 to repress endometrial cancer progression. Oncotarget. 2018;9(15):12064–12078. doi:https://doi.org/10.18632/oncotarget.24304